140 related articles for article (PubMed ID: 2782249)
1. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.
Ochi RP; Goldenberg IF; Almquist A; Pritzker M; Milstein S; Pedersen W; Gobel FL; Benditt DG
Am J Cardiol; 1989 Sep; 64(10):599-603. PubMed ID: 2782249
[TBL] [Abstract][Full Text] [Related]
2. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
Russo AM; Beauregard LM; Waxman HL
Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733
[TBL] [Abstract][Full Text] [Related]
3. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
Leak D
Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.
Kowey PR; Levine JH; Herre JM; Pacifico A; Lindsay BD; Plumb VJ; Janosik DL; Kopelman HA; Scheinman MM
Circulation; 1995 Dec; 92(11):3255-63. PubMed ID: 7586312
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
Schützenberger W; Leisch F; Kerschner K; Harringer W; Herbinger W
Br Heart J; 1989 Nov; 62(5):367-71. PubMed ID: 2590589
[TBL] [Abstract][Full Text] [Related]
6. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
[TBL] [Abstract][Full Text] [Related]
7. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
[TBL] [Abstract][Full Text] [Related]
10. An overview of antiarrhythmic drug management of electrical storm.
Kowey PR
Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
[TBL] [Abstract][Full Text] [Related]
11. Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults.
Perry JC; Knilans TK; Marlow D; Denfield SW; Fenrich AL; Friedman RA
J Am Coll Cardiol; 1993 Jul; 22(1):95-8. PubMed ID: 8509571
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of intravenous amiodarone in drug-resistant tachyarrhythmias of children.
Celiker A; Ceviz N; Ozme S
Acta Paediatr Jpn; 1998 Dec; 40(6):567-72. PubMed ID: 9893292
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
[TBL] [Abstract][Full Text] [Related]
15. High incidence of clinical and subclinical toxicity associated with amiodarone treatment of refractory tachyarrhythmias.
Anastasiou-Nana MI; Anderson JL; Nanas JN; Lutz JR; Smith RA; Anderson KP; Crapo RO; Call NB
Can J Cardiol; 1986; 2(3):138-45. PubMed ID: 2941121
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
[TBL] [Abstract][Full Text] [Related]
17. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.
Clemo HF; Wood MA; Gilligan DM; Ellenbogen KA
Am J Cardiol; 1998 Mar; 81(5):594-8. PubMed ID: 9514456
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone for refractory cardiac arrhythmias: 10-year study.
Leak D; Eydt JN
CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
